Rheumatoid nodule
WikiDoc Resources for Rheumatoid nodule |
Articles |
---|
Most recent articles on Rheumatoid nodule Most cited articles on Rheumatoid nodule |
Media |
Powerpoint slides on Rheumatoid nodule |
Evidence Based Medicine |
Cochrane Collaboration on Rheumatoid nodule |
Clinical Trials |
Ongoing Trials on Rheumatoid nodule at Clinical Trials.gov Trial results on Rheumatoid nodule Clinical Trials on Rheumatoid nodule at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Rheumatoid nodule NICE Guidance on Rheumatoid nodule
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Rheumatoid nodule Discussion groups on Rheumatoid nodule Patient Handouts on Rheumatoid nodule Directions to Hospitals Treating Rheumatoid nodule Risk calculators and risk factors for Rheumatoid nodule
|
Healthcare Provider Resources |
Causes & Risk Factors for Rheumatoid nodule |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
A rheumatoid nodule is a collection of normal cells including lymphocytes, and fibroblasts that surround a center of fibrinoid necrosis. They are usually subcutaneous especially over boney prominences such in the olecranon. About 5% of rheumatoid arthritis patients have such nodules within 2 years of disease onset, and the cumulative prevalence is about 25%.[1]
Rheumatoid lung nodules
Rheumatoid lung nodules must be differentiated from other cavitary lung lesions.
Causes of
lung cavities |
Differentiating Features | Differentiating radiological findings | Diagnosis
confirmation |
---|---|---|---|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
| |
|
|
||
|
|
| |
|
|
|
References
- ↑ Carmona L, González-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmartí R (2003). "Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity". Ann. Rheum. Dis. 62 (9): 897–900. PMC 1754657. PMID 12922967. Unknown parameter
|month=
ignored (help) . - ↑ 2.0 2.1 Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
- ↑ Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
- ↑ Onn A, Choe DH, Herbst RS, Correa AM, Munden RF, Truong MT, Vaporciyan AA, Isobe T, Gilcrease MZ, Marom EM (2005). "Tumor cavitation in stage I non-small cell lung cancer: epidermal growth factor receptor expression and prediction of poor outcome". Radiology. 237 (1): 342–7. doi:10.1148/radiol.2371041650. PMID 16183941.
- ↑ 5.0 5.1 Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Lee KS, Kim TS, Fujimoto K, Moriya H, Watanabe H, Tateishi U, Ashizawa K, Johkoh T, Kim EA, Kwon OJ (2003). "Thoracic manifestation of Wegener's granulomatosis: CT findings in 30 patients". Eur Radiol. 13 (1): 43–51. doi:10.1007/s00330-002-1422-2. PMID 12541109.
- ↑ Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, DePalo L, Hunninghake G, Iannuzzi MC, Johns CJ, McLennan G, Moller DR, Newman LS, Rabin DL, Rose C, Rybicki B, Weinberger SE, Terrin ML, Knatterud GL, Cherniak R (2001). "Clinical characteristics of patients in a case control study of sarcoidosis". Am. J. Respir. Crit. Care Med. 164 (10 Pt 1): 1885–9. doi:10.1164/ajrccm.164.10.2104046. PMID 11734441.
- ↑ Brauner MW, Grenier P, Mompoint D, Lenoir S, de Crémoux H (1989). "Pulmonary sarcoidosis: evaluation with high-resolution CT". Radiology. 172 (2): 467–71. doi:10.1148/radiology.172.2.2748828. PMID 2748828.
- ↑ Murphy J, Schnyder P, Herold C, Flower C (1998). "Bronchiolitis obliterans organising pneumonia simulating bronchial carcinoma". Eur Radiol. 8 (7): 1165–9. doi:10.1007/s003300050527. PMID 9724431.
- ↑ 10.0 10.1 Al-Ghanem S, Al-Jahdali H, Bamefleh H, Khan AN (2008). "Bronchiolitis obliterans organizing pneumonia: pathogenesis, clinical features, imaging and therapy review". Ann Thorac Med. 3 (2): 67–75. doi:10.4103/1817-1737.39641. PMC 2700454. PMID 19561910.
- ↑ Cordier JF, Loire R, Brune J (1989). "Idiopathic bronchiolitis obliterans organizing pneumonia. Definition of characteristic clinical profiles in a series of 16 patients". Chest. 96 (5): 999–1004. PMID 2805873.
- ↑ Lee KS, Kullnig P, Hartman TE, Müller NL (1994). "Cryptogenic organizing pneumonia: CT findings in 43 patients". AJR Am J Roentgenol. 162 (3): 543–6. doi:10.2214/ajr.162.3.8109493. PMID 8109493.
- ↑ Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.
- ↑ Moore AD, Godwin JD, Müller NL, Naidich DP, Hammar SP, Buschman DL, Takasugi JE, de Carvalho CR (1989). "Pulmonary histiocytosis X: comparison of radiographic and CT findings". Radiology. 172 (1): 249–54. doi:10.1148/radiology.172.1.2787035. PMID 2787035.